Reproductive health in women with systemic lupus erythematosus compared to population controls

References

• Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, et al. Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus. Medicine 1993; 72: 113–24
   PubMed Web of Science ®Google Scholar
• Gayed M, Gordon C. Pregnancy and rheumatic diseases. Rheumatology (Oxford) 2007; 46: 1634–40
   PubMed Web of Science ®Google Scholar
• Askanase AD, Buyon JP. Reproductive health in SLE. Best Pract Res Clin Rheumatol 2002; 16: 265–80
   PubMed Web of Science ®Google Scholar
• Khamashta MA, Hughes GR. Pregnancy in systemic lupus erythematosus. Curr Opin Rheumatol 1996; 8: 424–9
   PubMedGoogle Scholar
• Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum ;25 1982; 1982: 1271–7
   Google Scholar
• Helve T. Prevalence and mortality rates of systemic lupus erythematosus and causes of death in SLE patients in Finland. Scand J Rheumatol 1985; 14: 43–6
   PubMed Web of Science ®Google Scholar
• A Aromaa, Koskinen, S. Health and functional capacity in Finland. Baseline results of the Health 2000 health examination survey. Helsinki: National Public Health Institute, 2004.
   Google Scholar
• Fraga A, Mintz G, Orozco H. Fertility rates, fetal wastage and maternal morbidity in SLE. J Rheumatol 1974; 1: 293–8
   Web of Science ®Google Scholar
• Gonzales-Crespo MR, Gomez-Reino JJ, Merino R, Ciruelo E, Gomez-Reino FJ, Muley R, et al. Menstrual disorders in girls with systemic lupus erythematosus treated with cyclophosphamide. Br J Rheumatol 1995; 34: 737–41
   PubMedGoogle Scholar
• McDermott EM, Powell RJ. Incidence of ovarian failure in systemic lupus erythematosus after treatment with pulse cyclophosphamide. Ann Rheum Dis 1996; 55: 224–9
   PubMed Web of Science ®Google Scholar
• Contreras G, Tozman E, Nahar N, Metz D. Maintenance therapies for proliferative lupus nephritis: mycophenolate mofetil, azathioprine and intravenous cyclophosphamide. Lupus 2005; 14(Suppl 1)33–8
   Google Scholar
• Tinelli A, Tinelli R, Malvasi A, Cavallotti C, Tinelli FG. The intrauterine device in modern contraception: still an actuality?. Eur J Contracept Reprod Health Care 2006; 11: 197–201
   PubMed Web of Science ®Google Scholar
• Jungers P, Dougados M, Pelissier C. Influence of oral contraceptive therapy on the activity of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 618–23
   PubMed Web of Science ®Google Scholar
• Julkunen H. Oral contraceptives in systemic lupus erythematosus: side-effects and influence on the activity of SLE. Scand J Rheumatol 1991; 20: 427–33
   PubMed Web of Science ®Google Scholar
• Asherson RA, Harris EN, Hughes GRV, Farquharson RG. Complications of oral contraceptives and antiphospholipid antibodies. Arthritis Rheum 1988; 31: 575–6
   PubMed Web of Science ®Google Scholar
• Julkunen H, Kaaja R, Friman C. Contraceptive practice in women with systemic lupus erythematosus. Br J Rheumatol 1993; 32: 227–30
   PubMedGoogle Scholar
• Backman T. Benefit–risk assessment of the levonorgestrel intrauterine system in contraception. Drug Saf 2004; 27: 1185–204
   PubMed Web of Science ®Google Scholar
• Bruce IN. Atherogenesis and autoimmune disease: the model of lupus. Lupus 2005; 14: 687–90
   PubMed Web of Science ®Google Scholar
• Mok CC. Accelerated atherosclerosis, arterial thromboembolism, and preventive strategies in systemic lupus erythematosus. Scand J Rheumatol 2006; 35: 85–95
   PubMed Web of Science ®Google Scholar
• Petri M. Exogenous estrogen in systemic lupus erythematosus: oral contraceptives and hormone replacement therapy. Lupus 2001; 10: 222–6
   PubMed Web of Science ®Google Scholar
• Lakasing L, Khamashta M. Contraceptive practices in women with systemic lupus erythematosus and/or antiphospholipid syndrome: what advice should we be giving?. J Fam Plann Reprod Health Care 2001; 27: 7–12
   PubMedGoogle Scholar
• Sánchez-Guerrero J, González-Pérez M, Durand-Carbajal M, Lara-Reyes P, Jiménez-Santana L, Romero-Diaz J, et al. Menopause hormonal therapy in women with systemic lupus erythematosus. Arthritis Rheum 2007; 56: 3070–9
   PubMed Web of Science ®Google Scholar
• Petri M, Kim MY, Kalunian KC, Grossman J, Hahn BH, Sammaritano LR, et al. Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med 2005; 353: 2550–8
   PubMed Web of Science ®Google Scholar
• Tinzani A, Nuzzo M, Lojacono A, Cattalini M, Meini A. Review: contraception in adolescents with systemic lupus erythematosus. Lupus 2007; 16: 600–5
   PubMed Web of Science ®Google Scholar
• Gompel A, Piette JC. Systemic lupus erythematosus and hormone replacement therapy. Menopause Int 2007; 13: 65–70
   PubMedGoogle Scholar
• Buyon JP, Petri MA, Kim MY, Kalunian KC, Grossman J, Hahn BH, et al. The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial. Ann Intern Med 2005; 142: 953–62
   PubMed Web of Science ®Google Scholar
• Fernandez M, Calvo-Alén J, Bertoli AM, Bastian HM, Fessler BJ, McGwin G, Jr, et al. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA L II): relationship between vascular events and the use of hormone replacement therapy in postmenopausal women. J Clin Rheumatol 2007; 13: 261–5
   PubMed Web of Science ®Google Scholar
• Lima F, Buchanan NM, Khamashta MA, Kerslake S, Hughes GR. Obstetric outcome in systemic lupus erythematosus. Semin Arthritis Rheum 1995; 25: 184–92
   PubMed Web of Science ®Google Scholar
• Cortés-Hernandéz J, Ordi-Ros J, Paredes F, Casellas M, Castillo F, Vilardell-Tarres M. Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: a prospective study of 103 pregnancies. Rheumatology (Oxford) 2002; 41: 643–50
   PubMed Web of Science ®Google Scholar
• Silver RM, Branch DW. Autoimmune disease in pregnancy. Baillieres Clin Obstet Gynaecol 1992; 6: 565–600
   PubMed Web of Science ®Google Scholar
• Facts about social welfare and health care in Finland. 2006. Research and Development Centre for Welfare and Health (STAKES), Finland. Available online at:, , www.stakes.fi/NR/rdonlyres/FB044FF9-72F0-4EDA-8B02-EC2AE4AC966F/0/Facts2006.pdf. (accessed January 2008).
   Google Scholar
• Statistics and registers. National Institute for Health and Welfare, Finland. Available online at:, , www.stakes.fi/EN/tilastot/statisticsbytopic/reproduction/parturients.htm. (accessed January 2008).
   Google Scholar
• Julkunen H, Jouhikainen T, Kaaja R, Leirisalo-Repo M, Stephansson E, Palosuo T, et al. Fetal outcome in lupus pregnancy: a retrospective case–control study of 242 pregnancies in 112 patients. Lupus 1993; 2: 125–31
   PubMed Web of Science ®Google Scholar
• Petri M, Allbritton J. Fetal outcome of lupus pregnancy: a retrospective case–control study of the Hopkins lupus cohort. J Rheumatol 1993; 20: 650–6
   PubMed Web of Science ®Google Scholar
• Mok CC, Wong RW. Pregnancy in systemic lupus erythematosus. Postgrad Med J 2001; 77: 157–65
   PubMed Web of Science ®Google Scholar
• Julkunen H, Eronen M. Long-term outcome of mothers of children with isolated heart block in Finland. Arthritis Rheum 2001; 44: 647–52
   PubMed Web of Science ®Google Scholar
• Julkunen H, Miettinen A, Walle T, Chan EKL, Eronen M. Immune response in mothers of children with isolated congenital and acquired heart block: a population based study. J Rheumatol 2004; 31: 183–9
   PubMed Web of Science ®Google Scholar